Please login to the form below
brain
This page shows the latest brain news and features for those working in and with pharma, biotech and healthcare.
Novartis gains EU approval for relapsing MS drug Kesimpta
In people with MS, inflammatory immune cells such as lymphocytes can cross the blood brain barrier into the brain, damaging the protective sheath that insulates nerve cells – known as myelin.
Latest news
-
EMA updates product information for AZ COVID-19 vaccine
of clots in the vessels draining blood from the brain (CVST).
-
J&J’s multiple sclerosis therapy Ponvory moves closer to EU approval
In people with MS, inflammatory immune cells such as lymphocytes can cross the blood brain barrier into the brain, damaging the protective sheath that insulates nerve cells – known as myelin. ... Janssen's drug also showed statistically signifiant
-
J&J’s MS drug ponesimod receives approval in the US
J&J’s drug also outperformed Aubagio on fatigue scores, MRI assessments of the number of active lesions in the brain and the time to confirmed disability accumulation (CDA) – a measure
-
EMA review confirms AZ/Oxford's COVID-19 vaccine is safe and effective
of clots in the vessels draining blood from the brain (CVST).
-
Lilly to expand donanemab study in a bid for approval in Alzheimer’s disease
Although newly reported findings for secondary outcomes within this trial ‘showed no substantial difference’, Lilly highlighted exploratory analyses that showed donanemab slowed the accumulation of tau across key brain regions in
More from news
Approximately 3 fully matching, plus 616 partially matching documents found.
Latest Intelligence
-
A cultural shift in clinical research
levels, stress levels, breathing rate, and even different types of brain activity in real time.
-
The search for treatments for Parkinson’s disease
construct a device to deliver the therapy to precise areas of the brain in the hope of regenerating dying dopamine cells.
-
Managing virtual teams
Our brains react differently to seeing faces and hearing voices and these can help achieve more meaningful interactions.
-
Growing up as a patient is hard to manage
Ongoing brain development can pose as a threat to adherence. Not only do adolescents have underdeveloped impulse control that may be associated with rebellion against a healthcare provider or parental advice,
-
Case study: You vs Train
Due to the way their brains work and the impact of peer pressure, teenagers can struggle to weigh up the rational consequences of their actions in the heat of the moment.
More from intelligence
Approximately 0 fully matching, plus 57 partially matching documents found.
Latest appointments
-
Asceneuron appoints chief medical officer
His outstanding track record and expertise in neurodegenerative disease are crucial as we are about to progress our first highly brain penetrant and orally bioavailable tau modifier into the clinic for
-
Polleo Pharma co-founders join Chronos Therapeutics
In particular, their experience as co-founders of Polleo will be invaluable as we advance our behavioural brain disease portfolio.”.
-
Dr Niall Murphy and Pierre Schwich join Pharnext
He is currently an adjunct full professor of UCLA's department of psychiatry and biobehavioural sciences and a member of the Brain Research Institute at the David Geffen School of Medicine ... at the RIKEN Brain Science Institute.
-
Ex-GSK CEO Jean-Pierre Garnier takes up role at Alzheon
The firm focuses on brain health, memory and ageing and its lead product is an oral amyloid aggregation inhibitor that targets Alzheimer's disease.
-
Ovid Therapeutics adds member to scientific advisory board
Ovid is a privately-held biopharmaceutical company focused on developing therapies for rare and orphan diseases of the brain.
More from appointments
Approximately 0 fully matching, plus 9 partially matching documents found.
Latest from PMHub
-
Lucid Group Support Autism Awareness Day
Annually, 2 April is Autism Awareness Day. Being autistic does not mean you have an illness or disease; it means your brain works in a different way from other people.
-
Brain tumour awareness month: giving research a more humane face
group”. Nevertheless, there are green shoots of hope for the future of brain tumour research. ... Their research could find more effective ways of treating patients, including children, who suffer from brain tumours.
-
WHITE PAPER: What's missing in women's health?
Changes to the mind and body can mean that women no longer feel ‘like themselves’ alongside experiencing debilitating brain fog and even spells of depression. ... find out, what it does to our brain. Front Neurosci. 2014; 8.
-
Wilmington Healthcare appoints new Head of Digital
Mikko joins Wilmington Healthcare from the Brain Tumour Charity where, as Head of Digital, he led a team responsible for delivering digital marketing and communications plans across the organisation for income
-
The heavy toll of COVID-19 on cancer patients
This shortfall in money will mean that they will not be able to fund as many PhD and postdoctoral positions in the future – leading to a brain drain in the field.
More from PMHub
Approximately 3 fully matching, plus 84 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Freelance Medical Writer - Creative Healthcare Comms - 2 month t...
-
Excellent Day Rate
- Freelance Account Manager - Creative Healthcare Comms - Immediat...
-
Excellent Day Rate
-
Principal Medical Writer
-
Varies on experience
- Senior Leadership Role – Medical Communications – North West
-
Highly Competitive Salary, Bonus &Benefits
- Senior Content Editor - Biotechnology
-
Salary TBC
- FREELANCE Medical Writer, Senior Medical Writer, Principal Medic...
-
Highly Competitive Day Rate, Bonus &Benefits
- Senior Account / Programme Manager - MedComms - Buckinghamshire
-
Highly Competitive Remuneration packages
-
Account Management
-
Competitive Salary Offered
- Pfizer helps fund biotech venture from former researchers at closed Kent facility
- Oxford University to investigate nasal spray delivery of AZ-partnered COVID-19 vaccine
- First dose of Pfizer/BioNTech vaccine reduces COVID-19 infection risk by 70%
- Bayer’s finerenone scores FDA priority review for chronic kidney disease
- New restrictions for AZ/Oxford COVID-19 vaccine despite EMA endorsement
- Moderna launches COVID-19 vaccine booster study to address new variants
- WHITE PAPER: Why do men die younger?
- Opdivo improves survival in oesophageal cancer
- Opdivo plus chemotherapy increases response in pre-surgery NSCLC patients
- UPDATE: AZ/Oxford University COVID-19 vaccine gets EU approval
- Sanofi pays $160m upfront to acquire Tidal Therapeutics
- Roche, Regeneron’s COVID-19 antibody cocktail cuts infection risk
PMHub
SEVEN STONES
Seven Stones is a creative, independent healthcare communications agency of movers and thinkers. We've been doing health differently since 1991....
Latest intelligence
- WHITE PAPER: Why do men die younger?
- It’s a commonly accepted fact that women outlive men. Wherever you live, there’s a good chance that men will die on average eight years earlier than women. Is this an...
- 3 tips to show patient diversity in your clinical trial materials
- Here are some useful tips to help get your hands on authentically diverse stock photos....
- Virtual congresses: video thrilled the cardio tsar
- Chris Ross explores the key learnings from a year of virtual congresses...
Quick links
Infographics
